Ubichinon Compositum inj. sol. s.c./i.derm./i.m. amp.

Country: Belgium

Language: English

Source: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Active ingredient:

Acetylsalicylicum acidum D10 22 mg; Adenosinum triphosphoricum D10 22 mg; Ascorbicum acidum D6 22 mg; Coenzym A D10 22 mg; Coenzyme Q D10 22 mg; Colchicum autumnale D4 22 mg; Conium maculatum D4 22 mg; Galium aparine D6 22 mg; Histaminum D10 22 mg; Hydrastis Canadensis D4 22 mg; Magnesium Gluconicum D10 22 mg; Manganum phosphoricum D8 22 mg; Naphthoquinone D10 22 mg; Natrium diethyloxalaceticum D8 22 mg; Natrium Riboflavinum Phosphoricum D6 22 mg; Nadidum D10 22 mg; Nicotinamidum D6 22 mg; Para-Benzoquinonum D10 22 mg; Podophyllum peltatum D4 22 mg; Pyridoxinum Hydrochloricum D6 22 mg; Acidum L(+)-lacticum D6 22 mg; Sulfur. D8 22 mg; Thiaminum hydrochloridum D6 22 mg; Thioctic Acid D8 22 mg; Trichinoyl D10 22 mg; Vaccinium myrtillus D4 22 mg; Hydroquinone D8 22 mg; Anthraquinone D10 22 mg

Available from:

Heel Belgium SA-NV

Pharmaceutical form:

Solution for injection

Administration route:

Intradermal use; Intramuscular use; Subcutaneous use

Product summary:

CTI Extended: 661646-01

Authorization status:

Commercialised: No

Authorization date:

2023-07-20